Abrilada (adalimumab-afzb) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe hidradenitis suppurativa in adults.

Amjevita (adalimumab-atto) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe hidradenitis suppurativa in people age 12 and older.

Bimzelx (bimekizumab-bkzx) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe hidradenitis suppurativa.

Cosentyx (secukinumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe hidradenitis suppurativa in adults and children ages 12 years and older.

Cyltezo (adalimumab-adbm) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe hidradenitis suppurativa in people 12 years of age and older.

Hadlima (adalimumab-bwwd) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe hidradenitis suppurativa in adults.

Hulio (adalimumab-fkjp) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe hidradenitis suppurativa.

Humira (adalimumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe hidradenitis suppurativa in people 12 and older.

Hyrimoz (adalimumab-adaz) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe hidradenitis suppurativa in people 12 years of age and older.

Idacio (adalimumab-aacf) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe hidradenitis suppurativa in adults.

Simlandi (adalimumab-ryvk) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe hidradenitis suppurativa in people 12 years of age and older.

Yuflyma (adalimumab-aaty) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe hidradenitis suppurativa.

Yusimry (adalimumab-aqvh) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe hidradenitis suppurativa in adults.